2Babjuk M, Oosterlinck W, Sylvester R, et at. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update[J]. Eur Urol, 2011,59(6) :997-1008.
3Malmst~m PU, Sylvester R J, Crawford DE, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Gu6rin for non-muscle-invasive bladder cancer [ J ]. Eur Urol, 2009,56(2) :247-256.
4Shelley MD, Jones G, Cleves A, et al. Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC) : a sys- tematic review[J]. BJU Int, 2012,109(4) :496-505.
5Oddens JR, van der Meijden AP, Sylvester R. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe? [ J ]. Eur Urol, 2004,46 ( 3 ) :336-338.
